Cargando…
An electronic medical records-based approach to identify idiosyncratic drug-induced liver injury in children
Drug-induced liver injury (DILI) is the leading cause of liver failure in the United States and the most common cause of drug recall. As opposed to the recognized direct toxicity of super-therapeutic acetaminophen or chemotherapeutic agents in children, limited data exists for pediatric populations...
Autores principales: | Sandritter, Tracy L., Goldman, Jennifer L., Habiger, Clayton J., Daniel, James F., Lowry, Jennifer, Fischer, Ryan T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6888850/ https://www.ncbi.nlm.nih.gov/pubmed/31792283 http://dx.doi.org/10.1038/s41598-019-54075-4 |
Ejemplares similares
-
Immune mechanisms of idiosyncratic drug-induced liver injury
por: Mak, Alastair, et al.
Publicado: (2017) -
Description of an Innovative Pediatric Individualized Therapeutics Clinic: Working toward Precision Drug Therapy
por: Sandritter, Tracy L., et al.
Publicado: (2019) -
Update on Advances in Research on Idiosyncratic Drug-Induced Liver Injury
por: Kim, Seung-Hyun, et al.
Publicado: (2016) -
Idiosyncratic drug‐induced liver injury: A short review
por: Yamashita, Yo‐ichi, et al.
Publicado: (2017) -
Treatment of Idiosyncratic Drug-Induced Liver Injury Using Steroids
por: Sundaram, Suneha, et al.
Publicado: (2020)